Comments
Loading...

SCYNEXIS Insider Trading Activity

SCYXNASDAQ
Logo brought to you by Benzinga Data
$0.6301
0.00020.03%
Last update: Dec 18, 9:43 AM

SCYNEXIS Insider Trading Activity | NASDAQ:SCYX | Benzinga

Track the latest SCYNEXIS insider trading activity. Stay informed on recent buys, sells, and market impact for SCYNEXIS stock.

What is Insider Activity?

Insider trading activity involves company insiders, such as executives, directors, and employees, engaging in transactions of their own company's stock. Insiders' buy and sell transactions provide valuable insights into their confidence in the company's future performance.

What are SCYNEXIS Inc Insiders Doing?

Insiders have report no purchases/sales in the last 30 days.

Notable Recent Insider Buys and Sales

There has been no Insider buying or selling in the last 90 days.

Ownership Statistics for SCYNEXIS Inc

Shares Outstanding
41.965M
Insider Shares Owned
2.521M
Insider Percentage Owned
6.01%
Institutional Shares Held
6.705M
Institutional Percentage Held
16.0%
Sep 16, 2024David Gonzalez AnguloCHIEF EXECUTIVE OFFICER20.00K$1.37$27.40KBUY4.10%507.87KSep 12View
Apr 28, 2022Marco TagliettiCHIEF EXECUTIVE OFFICER75.00K$3.00$225.00KBUY38.06%272.07KApr 26View
Apr 28, 2022Scott SukenickGENERAL COUNSEL3.50K$3.00$10.50KBUY7.00%53.50KApr 26View
Jan 26, 2021PERCEPTIVE ADVISORS LLCPERCEPTIVE LIFE SCIENCES MASTER FUND LTDJOSEPH EDELMAN10% OWNER-599.00K$7.86-$4.71MSELL-24.97%1.80MJan 20 - Jan 22View
Dec 23, 2020Philippe Brian Tinmouth8.00K$6.25$50.00KPURCHASE8.00KDec 21View
Dec 23, 2020Marco Taglietti40.00K$6.25$250.00KPURCHASE57.42%109.67KDec 21View
Dec 23, 2020Scott Sukenick1.60K$6.25$10.00KPURCHASE21.34%9.10KDec 21View
Dec 23, 2020Guy Macdonald8.00K$6.25$50.00KPURCHASE200.00%12.00KDec 21View
Dec 23, 2020ANN HANHAM3.20K$6.25$20.00KPURCHASE758.29%3.62KDec 21View
Dec 23, 2020STEVEN GILMAN4.00K$6.25$25.00KPURCHASE4.00KDec 21View
Dec 23, 2020Eric Francois600.00$6.25$3.75KPURCHASE5.39%11.73KDec 21View
Dec 23, 2020ARMANDO ANIDO5.00K$6.25$31.25KPURCHASE5.00KDec 21View
Dec 23, 2020David Gonzalez Angulo1.60K$6.25$10.00KPURCHASE7.21%23.78KDec 21View
Dec 16, 2019Marco TagliettiCHIEF EXECUTIVE OFFICER166.67K$0.90$150.00KBUY31.62%693.68KDec 12View
Aug 22, 2019Marco TagliettiCHIEF EXECUTIVE OFFICER10.00K$1.11$11.10KBUY1.94%526.01KAug 20 - Aug 21View
Aug 19, 2019Marco TagliettiCHIEF EXECUTIVE OFFICER10.02K$1.01$10.12KBUY1.98%516.01KAug 15View
Apr 18, 2019Marco TagliettiCHIEF EXECUTIVE OFFICER25.00K$1.63$40.75KBUY5.20%506.00KApr 17View
Jan 14, 2019Marco TagliettiCHIEF EXECUTIVE OFFICER25.00K$0.69$17.25KBUY5.49%480.00KJan 10View
Jan 02, 2019Marco TagliettiCHIEF EXECUTIVE OFFICER25.00K$0.46$11.50KBUY5.81%455.00KDec 31View
Jan 02, 2019David Gonzalez AnguloCHIEF MEDICAL OFFICER12.00K$0.50$5.95KBUY10.93%121.79KDec 31View
Sep 10, 2018David Gonzalez AnguloCHIEF MEDICAL OFFICER7.00K$1.27$8.89KBUY6.88%108.79KSep 06View
Aug 27, 2018Marco TagliettiCHIEF EXECUTIVE OFFICER25.00K$1.29$32.25KBUY6.19%429.00KAug 23View
Apr 02, 2018David Gonzalez AnguloCHIEF MEDICAL OFFICER6.00K$1.36$8.16KBUY6.26%101.79KMar 29View
Mar 12, 2018David Gonzalez AnguloCHIEF MEDICAL OFFICER7.00K$1.39$9.73KBUY7.88%95.79KMar 08View
Mar 12, 2018DAVID HASTINGSDIRECTOR11.83K$1.69$20.00KBUY59.17%31.83KMar 08View
Mar 12, 2018Scott SukenickGENERAL COUNSEL2.96K$1.69$5.00KBUY2.96KMar 08View
Mar 12, 2018Marco TagliettiCHIEF EXECUTIVE OFFICER100.00K$1.69$169.00KBUY32.89%404.00KMar 08View
Mar 12, 2018Eric FrancoisCHIEF FINANCIAL OFFICER5.92K$1.69$10.00KBUY31.14%24.92KMar 08View
Mar 12, 2018David Gonzalez AnguloCHIEF MEDICAL OFFICER14.79K$1.69$25.00KBUY19.99%88.79KMar 08View
Sep 25, 2017Marco TagliettiCHIEF EXECUTIVE OFFICER10.00K$2.23$22.30KBUY3.41%303.00KSep 22View
Aug 24, 2017Marco TagliettiCHIEF EXECUTIVE OFFICER5.00K$1.85$9.25KBUY1.74%292.00KAug 22 - Aug 23View
Aug 17, 2017Marco TagliettiCHIEF EXECUTIVE OFFICER10.00K$1.61$16.10KBUY3.61%287.00KAug 15View
Aug 14, 2017David Gonzalez AnguloCHIEF MEDICAL OFFICER10.00K$1.55$15.50KBUY16.13%72.00KAug 11View
Jun 22, 2017DAVID HASTINGSDIRECTOR20.00K$1.75$35.00KBUY20.00KJun 21View
May 15, 2017Marco TagliettiCHIEF EXECUTIVE OFFICER25.00K$1.69$42.25KBUY9.92%277.00KMay 12View
May 15, 2017David Gonzalez AnguloCHIEF MEDICAL OFFICER15.00K$1.70$25.50KBUY31.91%62.00KMay 12View
Dec 22, 2016Marco TagliettiCHIEF EXECUTIVE OFFICER25.00K$3.30$82.50KBUY11.06%251.00KDec 21View
Dec 19, 2016David Gonzalez AnguloCHIEF MEDICAL OFFICER4.00K$3.25$13.00KBUY9.52%46.00KDec 16View
Sep 16, 2016Patrick MachadoDIRECTOR40.00K$2.94$117.60KBUY200.00%60.00KSep 15View
Jul 01, 2016David Gonzalez AnguloCHIEF MEDICAL OFFICER36.95K$2.22$82.16KBUY912.35%41.00KJun 29 - Jun 30View
Jun 28, 2016Patrick Clarence MachadoDIRECTOR20.00K$2.39$47.80KBUY20.00KJun 24View
Jun 28, 2016Eric FrancoisCHIEF FINANCIAL OFFICER15.00K$2.39$35.85KBUY15.00KJun 24View
Jun 28, 2016Marco TagliettiCHIEF EXECUTIVE OFFICER100.00K$2.39$239.00KBUY80.00%225.00KJun 24View
Jun 28, 2016Guy MacdonaldDIRECTOR40.00K$2.39$95.60KBUY40.00KJun 24View
May 27, 2016Marco TagliettiCHIEF EXECUTIVE OFFICER246.00$3.20$787.20BUY0.20%125.00KMay 25View
May 27, 2016ANN HANHAMDIRECTOR4.22K$3.64$15.38KBUY4.22KMay 25View
May 27, 2016Marco TagliettiCHIEF EXECUTIVE OFFICER5.75K$3.26$18.76KBUY4.84%124.75KMay 25View
May 25, 2016Marco TagliettiCHIEF EXECUTIVE OFFICER5.50K$3.37$18.54KBUY4.85%119.00KMay 24View
May 24, 2016Marco TagliettiCHIEF EXECUTIVE OFFICER7.50K$3.14$23.58KBUY7.08%113.50KMay 20 - May 23View
May 20, 2016Marco TagliettiCHIEF EXECUTIVE OFFICER6.00K$3.07$18.42KBUY6.00%106.00KMay 19View
Nov 24, 2015Marco TagliettiCHIEF EXECUTIVE OFFICER22.73K$6.79$154.43KBUY29.42%100.00KNov 23 - Nov 24View
Sep 18, 2015David Gonzalez AnguloCHIEF MEDICAL OFFICER3.00K$7.00$21.00KBUY3.00KSep 15View
Sep 02, 2015Marco TagliettiCHIEF EXECUTIVE OFFICER25.00K$7.82$195.50KBUY47.83%77.27KAug 31View
Aug 31, 2015Marco TagliettiCHIEF EXECUTIVE OFFICER2.27K$7.08$16.06KBUY4.53%52.27KAug 27 - Aug 28View
Aug 27, 2015Marco TagliettiCHIEF EXECUTIVE OFFICER50.00K$7.07$353.30KBUY50.00KAug 25 - Aug 26View
May 09, 2014Genavent FCPR10% OWNER237.60K$4.28$102.80KBUY237.60KMay 07View
May 08, 2014Fund Biotechnology FCPR10% OWNER295.08K$5.86$507.30KBUY295.08KMay 07View
May 08, 2014JeanYves NothiasDIRECTOR295.08K$5.86$507.30KBUY295.08KMay 07View
May 08, 2014ALTA BIOPHARMA PARTNERS II LPALTA BIOPHARMA MANAGEMENT II LLCALTA EMBARCADERO BIOPHARMA PARTNERS II LLCFarah Champsi10% OWNER1.29M$9.06$9.02MBUY45.74KMay 07View
May 08, 2014By: Mounia Chaoui venture Partner to Ventech10% OWNER414.21K$2.95$294.34KBUY414.21KMay 07View

FAQ

Q

Is insider trading legal?

A
Insider trading is legal so long as the insiders report those trades to the SEC. Illegal securities trading occurs when the insider is violating a fiduciary duty or fails to report their trades.
Q

What are some examples of market manipulation?

A
Insider trading, pump and dump schemes, front running and wash trades are all examples of market manipulation. Investors who track insider asset movement should think carefully about why these insiders are trading their stocks before moving forward.

Browse insider trades on all stocks.